BioPharma Credit (BPCR), the specialist life sciences lender, has announced two updates relating to its portfolio. Firstly, the company has received a US$30m partial prepayment from BioCryst Pharmaceuticals, relating to a senior secured term loan originally issued in 2023. The prepayment was part of a broader US$75m repayment announced by BioCryst during its Q1 2025 … Continue reading BioPharma Credit – Partial loan repayment and expanded Evolus facility